These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 29937437)
21. [Application of gene technology in the diagnosis of familial hypercholesterolemia]. Leren TP; Bakken KS; Rødningen OK; Gundersen KE; Sundvold H; Berg K; Tonstad S; Ose L Tidsskr Nor Laegeforen; 1997 Feb; 117(5):678-81. PubMed ID: 9102960 [TBL] [Abstract][Full Text] [Related]
22. Genetic analysis of familial hypercholesterolaemia in Western Australia. Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975 [TBL] [Abstract][Full Text] [Related]
23. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB). Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954 [TBL] [Abstract][Full Text] [Related]
24. Large heterogeneity of mutations in the gene encoding the low-density lipoprotein receptor in subjects with familial hypercholesterolaemia. Muller PY; Miserez AR Atheroscler Suppl; 2004 Dec; 5(5):1-5. PubMed ID: 15556092 [TBL] [Abstract][Full Text] [Related]
25. Familial hypercholesterolaemia in a Belgian community. Descamps OS Acta Cardiol; 2000 Dec; 55(6):327-33. PubMed ID: 11227832 [TBL] [Abstract][Full Text] [Related]
26. Mutational analysis and genotype-phenotype relation in familial hypercholesterolemia: The SAFEHEART registry. Bourbon M; Alves AC; Alonso R; Mata N; Aguiar P; Padró T; Mata P Atherosclerosis; 2017 Jul; 262():8-13. PubMed ID: 28475941 [TBL] [Abstract][Full Text] [Related]
27. Managing homozygous familial hypercholesterolaemia from cradle to grave. Thompson GR Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299 [TBL] [Abstract][Full Text] [Related]
29. Familial Hypercholesterolaemia in the Era of Genetic Testing. Hughes DP; Viljoen A; Wierzbicki AS Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618 [TBL] [Abstract][Full Text] [Related]
30. Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia - a proof-of-concept study. Maurer F; Pradervand S; Guilleret I; Nanchen D; Maghraoui A; Chapatte L; Bojkowska K; Bhuiyan ZA; Jacquemont N; Harshman K; Mooser V Swiss Med Wkly; 2016; 146():w14326. PubMed ID: 27497240 [TBL] [Abstract][Full Text] [Related]
31. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Umans-Eckenhausen MA; Defesche JC; Sijbrands EJ; Scheerder RL; Kastelein JJ Lancet; 2001 Jan; 357(9251):165-8. PubMed ID: 11213091 [TBL] [Abstract][Full Text] [Related]
32. Clinical implications of the molecular basis of familial hypercholesterolemia and other inherited dyslipidemias. Kwiterovich PO Circulation; 2011 Mar; 123(11):1153-5. PubMed ID: 21382891 [No Abstract] [Full Text] [Related]
33. Diagnosis and treatment of familial hypercholesterolaemia. Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791 [TBL] [Abstract][Full Text] [Related]